Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Standing up to Rising Prescription Drug Costs Increases Access to Breakthrough Medications
CVS Caremark negotiated a price reduction for Yeztugo, a long‑acting injectable PrEP drug with an original list price of $28,000 per year, to improve affordability and access. The medication offers twice‑yearly dosing, which can dramatically boost adherence compared with daily oral regimens. By leveraging its scale, CVS aims to lower barriers for high‑risk groups, especially Black and Hispanic men, amid a surge in new HIV diagnoses. The initiative reflects growing industry pressure to curb prescription drug costs and expand preventive care options.
Re: Prognostic Score for Predicting Respiratory Admissions Among Patients with Chronic Obstructive Pulmonary Disease in Primary Care: Development and Validation...
Researchers responded to feedback on their COPD admission risk score, noting that among six candidate predictors only diabetes remained statistically significant. The model, built on the Birmingham Lung Improvement Studies (BLISS) dataset, was externally validated in the ECLIPSE and CPRD...
The Hollow Promise of Protection
A Singapore study led by Wee et al. examined thousands of cancer patients who were fully vaccinated with mRNA COVID‑19 shots. Despite high vaccination rates, most participants contracted COVID‑19 and developed long‑COVID symptoms such as fatigue, dyspnea, and cognitive impairment....
Stereotaxis Launches Synchrony System for Cath Labs
Stereotaxis has received FDA 510(k) clearance to launch Synchrony, a digital platform for cardiac catheterization labs. The system features a 55‑inch 4K ultra‑high‑definition display that unifies control of disparate equipment and delivers full‑fidelity video with ultra‑low latency. Accompanying the hardware,...
CGT’s Next Obstacle: Securing the Leukapheresis Supply Chain
Leukapheresis is emerging as a structural bottleneck as CAR‑T and other cell‑gene therapies expand beyond oncology into autoimmune, cardiovascular and respiratory diseases. The current model relies on a handful of academic centers, creating capacity constraints, geographic inequities, and variability in...
Disruption Expected as Six-Day Doctors' Strike Begins
Resident doctors in England launched a six‑day strike, their 15th action over pay, prompting emergency cover and cancellation of some treatments. The NHS says 95% of appointments remain, while the government estimates the disruption costs £50 million daily, about £3 billion since...
CuraTeQ Reports P-III Trial Data on BP11 (Biosimilar, Xolair) in Chronic Spontaneous Urticaria
CuraTeQ Biologics announced topline Phase‑III data showing its biosimilar BP11 matches Xolair in treating chronic spontaneous urticaria. The trial involved 608 patients at about 80 sites and met the primary endpoint of ISS7 score change at week 12 within predefined...
UK Steps up Push to Align Medtech Regulations with the US
The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced a new collaboration with the US Food and Drug Administration to align medical‑device regulations. The partnership will explore mutual‑recognition mechanisms, allowing FDA‑cleared devices to fast‑track through UK reviews while preserving...
Newborn DNA Screening: What’s Changing in the UK and Where Private Testing Fits
In England, the NHS heel‑prick blood spot test currently screens newborns for nine rare conditions. A 2024 Genomics England Generation Study is sequencing 100,000 infants to evaluate whole‑genome screening for over 200 treatable disorders, with a national rollout planned for...
Eligibility for Care at Ilford Park Polish Home: Who Can Apply
Ilford Park Polish Home in Devon has opened admissions for individuals eligible under the 1947 Polish Resettlement Act. The facility can accommodate up to 95 residents, offering residential, nursing and sheltered care, with bilingual staff and daily Polish Catholic services....
DISTURBING: Canadian Doctors Suggest Harvesting Organs From Euthanasia Patients BEFORE THEY’RE DEAD
Canadian physicians, led by ethicist Rob Sibbald, have publicly suggested harvesting organs from patients undergoing medically assisted dying (MAID) before they are declared dead, challenging the long‑standing dead donor rule. Since Canada legalized euthanasia in 2016, MAID cases have surged,...
How Smart Practices Improve Cash Flow Without Losing Focus on Care
Medical billing sits at the nexus of clinical care and revenue, and small errors can halt cash flow, costing practices thousands each year. The article outlines how routine audits, clear patient statements, and strategic billing models—whether in‑house, hybrid, or fully...
Amgen Reports Topline P-III Trial Data for Tepezza (Teprotumumab-Trbw) in Active Thyroid Eye Disease
Amgen announced topline results from a phase‑3 trial of subcutaneous Tepezza (teprotumumab‑trbw) administered every two weeks for 12 doses in patients with moderate to severe active thyroid eye disease. The study met its primary endpoint, showing a 76.7% proptosis response...
Legislative Alchemy: Licensing Reflexologists and Other Practitioners of Pseudoscience
States across the U.S. are introducing bills that would license reflexologists and other alternative‑medicine practitioners, a process the author dubs “Legislative Alchemy.” The North Carolina Healing Arts Act, Massachusetts Senate Bill 261, and Iowa House File 2178 each propose new regulatory boards...
Canagliflozin - Another Top Longevity Drug
Canagliflozin and other SGLT‑2 inhibitors are gaining attention as potential longevity agents due to their ability to cut cardiovascular events, renal decline, and COPD exacerbations in patients with type‑2 diabetes. Recent meta‑analyses show reduced emergency‑room visits and lower mortality among...
Life Expectancy in the USA and Around the World
The article highlights a surge in avoidable mortality as Europe ages, linking air pollution to cardiovascular risk and noting a sharp decline in the United Kingdom's healthy life expectancy to 61 years. In the United States, liberal states have achieved...
Weight Rebound Is Inevitable After Stopping GLP‑1s
Why weight regain is a predictable biological response after stopping GLP-1s [PODCAST] http://dlvr.it/TRvfHv Podcast #Diabetes
Self‐Assembled Carrier‐Free Nanomedicines Potentiate Chemo‐Photothermal Immunotherapy by Overcoming Prostaglandin E2‐Mediated Immunosuppression
Researchers have created a carrier‑free nanomedicine that self‑assembles indocyanine green, paclitaxel and celecoxib to treat triple‑negative breast cancer (TNBC). The formulation delivers combined chemo‑photothermal therapy while inhibiting the COX‑2/PGE2 inflammatory axis that fuels immunosuppression. In preclinical models, the nanomedicine markedly...
Programmable Biohybrid Probiotics with Long‐Term Storage Stability for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment
Researchers unveiled a multilayer encapsulation platform that merges a metal‑polyphenol network, silica shell, and iron‑based metal‑organic framework to shield the anaerobic probiotic Bifidobacterium longum. The system achieved a 41‑fold boost in aerobic storage stability and an 871‑fold increase in gastric...
Sanofi Reports P-II Trial Results on Lunsekimig Across Multiple Immunology & Inflammatory Indications
Sanofi announced phase‑IIb results for its subcutaneous antibody lunsekimig across three inflammatory diseases. In the AIRCULES asthma study, the drug reduced exacerbations and improved pre‑bronchodilator FEV1 versus placebo, meeting both primary and key secondary endpoints. The DUET trial in chronic...
Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen
In this episode, Emma Vitalini, Head of Global Digital Health Technology Innovation at Amgen, discusses how AI and decentralized trial technologies are transforming patient recruitment, screening, and global trial accessibility. She explains that AI can rapidly parse unstructured genomic and...
Zeus Adds Catheter Components to Chamfr Marketplace
Zeus, a global polymer and catheter manufacturer, has added over 100 liner and heat‑shrink components to Chamfr’s online marketplace. The catalog now includes PTFE liners, FEP heat‑shrink tubing and the FluoroPEELZ peelable shrink, giving engineers on‑demand access to critical materials....
Press Release: Sanofi’s Lunsekimig Met Primary and Key Secondary Endpoints in Phase 2 Respiratory Studies in Asthma and CRSwNP
Sanofi announced that its bispecific Nanobody lunsekimig achieved both primary and key secondary endpoints in the phase 2b AIRCULES asthma trial and the phase 2a DUET study for chronic rhinosinusitis with nasal polyps (CRSwNP). The asthma study showed a statistically...
Building a Global Movement: How Food Is Medicine Is Transforming Healthcare Worldwide
Researchers, clinicians, and funders from 12 countries gathered at the Rockefeller Foundation’s Bellagio Center in September 2025 to launch a global Food is Medicine (FIM) movement. The convening produced eight consensus principles that define how nutrition‑based interventions should be integrated,...
Stop, Reduce or Stay on Antipsychotics After First-Episode Psychosis?
A recent pragmatic RCT followed 347 first‑episode psychosis patients to compare continued antipsychotic maintenance with gradual dose reduction or discontinuation. In the first year, the reduction group faced a higher relapse rate, lower quality of life, and increased mortality. By...
Iran War Delays Vital Reproductive Aid for Women Across the Globe
Disruptions from the Iran war are delaying critical reproductive health supplies to more than a dozen countries, according to the United Nations Population Fund (UNFPA). Shipments of labor‑room equipment, surgical tools, assisted‑delivery devices and over 1.2 million male condoms for 45...
Empowering Women to Defy Healthcare Inequities
Someone asked me recently what drives me. It’s an easy answer. I’ve spent my career watching women be undertreated, underinformed, and underestimated by a healthcare system that has repeatedly failed them. So here’s my mission: I help women defy the conditions that threaten...
Kent and Medway Mental Health Trust Unifies Youth Services in Landmark Merger
From April 2026 the Kent and Medway Mental Health NHS Trust took over children and young people's mental health services, joining them with adult and eating‑disorder care. The merger creates the first single‑trust model for the region and promises smoother...
Brown Fat Protein SLIT3 Unlocked as Key to Metabolism, Weight‑Loss Potential
Researchers published in Nature Communications have identified a dual‑fragment protein system, SLIT3‑N and SLIT3‑C, that constructs the vascular and neural scaffolding essential for brown adipose tissue to burn calories. The discovery, based on analysis of more than 1,500 human samples,...
EU‑Funded PsyPal Project Starts Psychedelic Trials for Palliative Care Distress
The European Union‑funded PsyPal project kicked off its first psychedelic‑assisted therapy trials for psychological distress in palliative care on 13 April 2026 in Brussels. The launch, hosted by the Directorate‑General for Health and Food Safety, signals a coordinated effort to...
AI and Biometrics Power New Wave of Autonomous Mindfulness Apps
Developers of next‑generation mindfulness platforms are rolling out AI‑powered tools that read heart‑rate variability, skin conductance and sleep data to deliver instant stress‑relief interventions. A University of Bern study of 830 users showed sustained reductions in stress after eight weeks,...
Catalyst Precision Health Launches First At‑home Men’s Longevity Service
Catalyst Precision Health, founded by Dr. Westley Spiro and Matt Renart, introduced the first at‑home, subscription‑based longevity platform for men, bundling in‑home lab draws, physician house calls and ongoing personalized treatment. The launch targets a $600 billion global longevity market and...
Interventional Radiologist 1st in World to Deliver Newly Approved Cancer Treatment
Interventional radiologists at Mount Sinai performed the world’s first TheraSphere Y‑90 Any Day Dosing procedure for hepatocellular carcinoma, following the FDA’s March 2026 clearance. The treatment uses microspheres to deliver targeted radiation directly to liver tumors while sparing healthy tissue. The...
UK Lawmakers Warn Palantir, Putting CEO Mosley and Board Under Regulatory Heat
Palantir Technologies faces a fresh political onslaught in the United Kingdom as MPs question its £330 million NHS data platform and defense contracts. Executive Vice President Louis Mosley defended the firm’s role in a BBC interview, but lawmakers warned the company...
Self‑Administered Peptide Clinics Surge After Huberman Podcast, Raising Safety Concerns
After a 2024 appearance on Andrew Huberman’s podcast, Dr. Koniver’s peptide‑focused clinic added 800 new patients in a month, now serving about 1,000 and maintaining a 6,000‑person waitlist. Memberships cost $15,000 a year, generating tens of millions in revenue, while...
MAHA ELEVATE Part II: Should You Apply? And If Yes, Where Do You Actually Start?
CMS has launched the MAHA ELEVATE $100 million cooperative agreement, inviting up to 30 organizations to run randomized, evidence‑generating lifestyle and functional‑medicine trials in the Original Medicare population. A non‑binding Letter of Intent is due by April 10 5 pm ET, with full applications required by...
What Would Robert Louis Stevenson Say About Ozempic?
The article warns that GLP‑1 drugs such as Ozempic, Wegovy and Mounjaro, while effective for weight loss, may blunt dopamine‑driven pleasure centers, leading to apathy and altered behavior. It draws a parallel between these modern injectables and the historic side...
Try Loading, Not Surgery, for Degenerative Joint Tears
Fake surgery is just as good as actual surgery. For these conditions. Degenerative Rotator Cuff Tear Degenerative Meniscal Tears Subacromial Decompression for Shoulder Pain Whenever surgery is recommended make sure to FIRST ask what happens if you load it instead.
OHGR Lands 3‑year Sheffield Deal; Valuation Dips, Modest Dividend
#OHGR got Sheffield Teaching Hospital to sign up to 3 year deal. ShareScope has fwd p/e 19 falling to 18 and fwd Divvy 2.6% each of next 2 years. Interesting with NHS a national disgrace. I don't hold.
OPM Shifts Federal Health Plans to ‘Well‑Care’ Model for 2027
The U.S. Office of Personnel Management released its annual call letter in late March 2026, setting 2027 policy goals that brand the next year’s federal health benefits as “well‑care.” The guidance expands preventive services, obesity treatment, and fertility support while...
Lower Cholesterol Linked to Reduced Dementia Risk
Does lowering cholesterol harm the brain? A large genetic study suggests lifelong reductions in atherogenic lipoproteins are associated with lower—not higher—dementia risk. https://t.co/QutNZzb4PH https://t.co/T84ZLIKq4A
Gender‑affirming Care Is a Medical, Not Civil‑rights Issue
My view on the issue of gender-affirming care has always been that it should be treated as a MEDICAL issue, rather than as a civil rights issue. Activists can conflate the two for a long time, but not forever.
UCL Unveils Diet-MisRAT Tool to Grade Online Nutrition Misinformation Risk
University College London scientists have released the Diet‑Nutrition Misinformation Risk Assessment Tool (Diet‑MisRAT), a rule‑based platform that rates the potential health harm of online nutrition claims. Calibrated with input from nearly 60 public‑health and dietetics experts, the tool moves beyond...
Humanoid Robots Set to Transform Hospitals and Homes
Humanoid #Robots Designed to Enhance Daily Life in Hospitals and Homes via @ZappyZappy7 #EmergingTech #Technology #Innovation #TechForGood https://t.co/Mbb3aFNNLo
Addressing Climate Health, Vaccines, and Antivaccine Threats at Darwin Day
I look forward to giving talks and lectures this coming weekend @uiowa for their Darwin Day celebrations, speaking on climate health, global vaccines, and the dangers of rising antivaccine activism https://t.co/qjv3pnN3oB https://t.co/ISy1vMm9hG
Study Shows 88% Accuracy for OTC Medication Abortion Kit Self‑Assessment
A new JAMA Internal Medicine study reports that 88% of participants accurately judged their eligibility for an over‑the‑counter medication abortion kit, suggesting self‑assessment could be safe. The findings arrive amid state bans and a lack of FDA applications, intensifying calls...
AI Meets Drug Discovery at NYC Meetup Tuesday
AI x Drug Discovery meetup next Tues (14) in NYC ! @ginkgo excited to host with @AAlphaBio — sign up here : https://t.co/GG5c7F4ogO
209. Will Trump's Pharmaceutical Tariffs Lower Prices and Secure Supply Chains?
In this episode, host Chad Bowne and guest Tom Boyke dissect the Trump administration’s new pharmaceutical tariffs and the U.S.-U.K. pricing arrangement, explaining how they aim to address two distinct challenges: low‑margin generic drug shortages tied to China and India,...
Towards Scalable Biomarker Discovery in Posttraumatic Stress Disorder: Triangulating Genomic and Phenotypic Evidence From a Health System Biobank
Researchers leveraged a large health‑system biobank to combine genomic polygenic risk scores with electronic health‑record phenotypes, creating a scalable pipeline for PTSD biomarker discovery. The analysis identified immune‑related and metabolic signatures that correlate with PTSD risk, and highlighted sex‑specific genetic...
The Hart Of It All with Teri Hart
In the inaugural episode of "The Heart of It All," host Terri Hart shares her personal journey transitioning from caring for her father to supporting her mother, highlighting the emotional rollercoaster of caregiving. She discusses the challenges of shifting family...